TScan Therapeutics (TCRX)
(Delayed Data from NSDQ)
$5.71 USD
-0.15 (-2.56%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $5.69 -0.02 (-0.35%) 7:20 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.30 | 0.00% |
Earnings Summary
For their last quarter, TScan Therapeutics (TCRX) reported earnings of -$0.32 per share, missing the Zacks Consensus Estimate of -$0.25 per share. This reflects a negative earnings surprise of 28.00%. Look out for TCRX's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.30 per share, reflecting a year-over-year increase of 41.18%.
Earnings History
Price & Consensus
Zacks News for TCRX
TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates
TCRX: What are Zacks experts saying now?
Zacks Private Portfolio Services